Gongdong Medical: Shareholders holding more than 5% of the shares reduce their holdings, resulting in a change in equity of 1%.

Archedong Medical announced that from October 9th to 30th, 2025, the company's shareholder Taizhou Jincheng Investment Management Partnership Enterprise reduced its holdings by 540,240 shares through centralized bidding. After this equity change, Jincheng Investment and its concerted action person collectively held shares decreased from 141.558049 million shares to 141.017809 million shares, and the shareholding ratio decreased from 64.21% to 63.96%, triggering the 1% scale. This change is to fulfill the reduction plan and does not trigger a tender offer, does not affect the controlling rights of the company, and the reduction plan has not been completed yet.